![]() |
市场调查报告书
商品编码
1331409
植物性辅料市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测,按类型、按应用、地区和竞争细分Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By Region and Competition |
由于包括製药在内的各行业对天然和可持续产品的需求不断增长,全球植物基辅料市场预计在预测期内将以令人印象深刻的速度增长。植物性辅料被视为比传统辅料更可持续、更环保的替代品,传统辅料通常源自石油等不可再生来源。消费者越来越关注产品对环境的影响,并寻求更可持续的替代品。全球消费者和政府将焦点转向可持续发展,预计将为未来几年全球植物性辅料市场的增长创造新的前景。
近年来,植物性赋形剂在药物製剂中的使用越来越受到关注。这是由于对药品中天然、可持续和安全成分的需求不断增长。与传统赋形剂相比,植物性赋形剂具有多种优点,包括更好的溶解度、更高的生物利用度和更低的毒性。为了支持植物性辅料的发展,已经制定了几项有利的法规。这些法规鼓励在药品中使用天然和可持续成分,并促进创新植物辅料的开发。 FDA 的 GRAS(公认安全)清单是被认为可安全用于食品和药品的物质清单。该列表包括几种植物性赋形剂,例如纤维素、淀粉和果胶。将这些辅料列入 GRAS 清单鼓励了它们在药物製剂中的使用,因为它们被认为是安全的,不需要进行广泛的安全测试。反过来,预计这将为全球植物性辅料市场的增长创造利润丰厚的机会。此外,欧洲药典是欧洲药品的一套标准和指南。药典包括几部关于植物性赋形剂的专着,例如微晶纤维素、淀粉和乳糖。这些专着提供了有关这些赋形剂的质量和规格的详细信息,这鼓励了它们在药物製剂中的使用。此外,国际药用辅料理事会 (IPEC) 还提供有关药用辅料(包括植物性辅料)的质量和安全性的指南。这些指南确保植物性辅料符合药品中使用的必要质量标准。这种支持性的监管环境预计将在未来几年促进全球植物性辅料市场的增长。
多年来,由于植物辅料的成本效益和对患者健康的不良反应较小,与植物辅料相关的研究显着增加。近年来,植物性辅料作为製药行业传统辅料的更可持续、更环保的替代品而受到广泛关注。因此,人们对植物性辅料的特性和应用进行了大量的研究,从而为全球植物性辅料市场的增长创造了新的前景。例如,海藻酸盐是一种从褐海藻中提取的多醣,已被用作药物赋形剂。最近的研究重点是开发基于藻酸盐的赋形剂,可用于提高难溶性药物的溶解度和生物利用度。基于藻酸盐的赋形剂还被发现具有粘膜粘附特性,使其适合用于针对体内特定部位的药物递送系统。同样,纤维素是一种存在于植物中的天然聚合物,已被用作药物的赋形剂。最近的研究重点是开发可用于提高药物稳定性和溶解度的纤维素基赋形剂。人们还发现基于纤维素的赋形剂具有抗氧化特性,使其适合用于开发针对氧化压力相关疾病的药物。
总之,最近的研究重点是开发可用于提高药物的溶解度、稳定性和生物利用度的植物性赋形剂。海藻酸盐、纤维素、淀粉、蛋白质和树胶等植物性赋形剂在製药行业的各种应用中显示出良好的前景。随着该领域研究的不断推进,预计将开发出更多植物基辅料并用于新药的开发,从而支持全球植物基辅料市场的增长。
根据给定的市场数据,TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项:
Global Plant Based Excipients Market is expected to grow at an impressive rate during the forecast period on account of the growing demand for natural and sustainable products in various industries, including pharmaceuticals. Plant-based excipients are seen as a more sustainable and eco-friendlier alternative to traditional excipients, which are often derived from non-renewable sources such as petroleum. Consumers are increasingly concerned about the environmental impact of products and are seeking more sustainable alternatives. The shifting focus of consumers and governments across the globe towards sustainability is expected to create new prospects for the growth of global plant based excipients market in the coming years.
Plant based excipients are derived from natural sources such as algae, starches, cellulose, gums, and proteins and are used to improve the stability, solubility, and bioavailability of drugs. Plant based excipients are considered safer than traditional excipients because they are derived from natural sources and are less likely to cause adverse reactions in patients. In addition, plant based excipients are free from potential contaminants and impurities that may be present in synthetic excipients. This, in turn, is expected to drive the growth of global plant based excipients market during the forecast period.
There has been a growing trend towards using plant based excipients in combination with other natural ingredients. For example, Hydroxy Propyl Methyl Cellulose (HPMC), a widely used plant based excipient, has been combined with natural gums such as guar gum, xanthan gum, and locust bean gum to improve tablet hardness and disintegration. This approach has resulted in a more natural and sustainable product while maintaining the required quality and efficacy of the drug. This, in turn, is expected to spur the demand for plant based excipients thereby driving the growth of global plant based excipients market in the next few years.
In recent years, there has been an increasing focus on the use of plant-based excipients in pharmaceutical formulations. This is due to the growing demand for natural, sustainable, and safe ingredients in pharmaceutical products. Plant-based excipients offer several benefits over traditional excipients, including better solubility, improved bioavailability, and reduced toxicity. To support the growth of plant-based excipients, there have been several favorable regulations put in place. These regulations encourage the use of natural and sustainable ingredients in pharmaceuticals and promote the development of innovative plant-based excipients. The FDA's GRAS (Generally Recognized as Safe) list is a list of substances that are considered safe for use in food and pharmaceutical products. The list includes several plant-based excipients such as cellulose, starch, and pectin. The inclusion of these excipients on the GRAS list has encouraged their use in pharmaceutical formulations, as they are considered safe and do not require extensive safety testing. This, in turn, is expected to create lucrative opportunities for the growth of global plant-based excipients market. Additionally, The European Pharmacopoeia is a set of standards and guidelines for pharmaceutical products in Europe. The pharmacopeia includes several monographs on plant-based excipients, such as microcrystalline cellulose, starch, and lactose. These monographs provide detailed information on the quality and specifications of these excipients, which has encouraged their use in pharmaceutical formulations. Also, the International Pharmaceutical Excipients Council (IPEC) provides guidelines on the quality and safety of pharmaceutical excipients, including plant-based excipients. These guidelines ensure that plant-based excipients meet the necessary quality standards for use in pharmaceutical products. Such a supportive regulatory environment is expected to foster the growth of global plant-based excipients market in the coming years.
Over the years, research related to plant based excipients has significantly increased on account of their cost-effectiveness and lesser adverse reactions to patient health. Plant based excipients have gained a lot of attention in recent years as a more sustainable and eco-friendlier alternative to traditional excipients in the pharmaceutical industry. As a result, there has been a significant amount of research conducted on the properties and applications of plant-based excipients, thereby creating new prospects for the growth of global plant based excipients market. For instance, alginate is a polysaccharide that is derived from brown seaweed and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of alginate-based excipients that can be used to improve the solubility and bioavailability of poorly water-soluble drugs. Alginate-based excipients have also been found to have mucoadhesive properties, making them suitable for use in drug-delivery systems that target specific sites in the body. Similarly, cellulose is a natural polymer that is found in plants and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of cellulose-based excipients that can be used to improve the stability and solubility of drugs. Cellulose-based excipients have also been found to have antioxidant properties, making them suitable for use in the development of drugs that target oxidative stress-related diseases.
In conclusion, recent research has focused on the development of plant-based excipients that can be used to improve the solubility, stability, and bioavailability of drugs. Plant-based excipients such as alginate, cellulose, starch, proteins, and gums have shown promise in various applications in the pharmaceutical industry. As research in this field continues to advance, it can be expected that more plant based excipients will be developed and used in the development of new drugs, thereby supporting the growth of global plant based excipients market.
Global Plant Based Excipients Market can be segmented by type, application, and by region. Based on type, the Global Plant Based Excipients market can be categorized into carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, and others. By application, the Global Plant Based Excipients market can be fragmented into binders & diluents, glidants, lubricants & disintegrants, film forming & coating agents, plasticizers, suspending agents, and others. Regionally, the Global Plant Based Excipients market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Among different countries, United States is expected to dominate the global plant based excipients market. In the United States, there has been a growing interest in plant based excipients due to the increasing demand for natural and sustainable ingredients. The FDA has recognized many plant-based excipients as Generally Recognized as Safe (GRAS) for use in pharmaceuticals. The use of plant-based excipients in cosmetics is also gaining popularity due to the trend toward natural and organic products. This, in turn, will support the growth of plant based excipients market.
Roquette Freres SA, EVONIK Industries, Inc., DFE Pharma GmbH & Co.KG, Lonza Group, BASF SE, Novartis International AG, FMC Corporation, JRS Pharma LP, among others, are some of the leading players operating in the Global Plant Based Excipients market.
In this report, Global Plant Based Excipients Market has been segmented into following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Plant Based Excipients Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: